Kronos Bio (KRON) Earnings Date & Reports

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KRON is expected to report earnings to fall 30.23% to -30 cents per share on May 07

Q1'25

Est.

$-0.30

Q4'24

Missed

by $0.17

Q3'24

Beat

by $0.05

Q2'24

Beat

by $0.09

Q1'24

Missed

by $0.08

The last earnings report on March 18 showed earnings per share of -43 cents, missing the estimate of -25 cents. With 65.82K shares outstanding, the current market capitalization sits at 50.30M.

View a ticker or compare two or three

Compare

KRON